Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION-46L enhanced in vivo MRI: Early histopathological correlation

Journal of Neuroscience Research

Volumn 52, Issue 5, 1998, Pages 549-558

  Xu, Su ^a   Jordan, E Kay ^a   Brocke, Stefan ^b   Bulte, Jeff W M ^a   Quigley, Laura ^b   Tresser, Nancy ^b   Ostuni, John L ^a   Yang, Yihong ^a   McFarland, Henry F ^b   Frank, Joseph A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Contrast agent enhanced; EAE mouse; In vivo MRI; MOIN 46L iron oxide

Indexed keywords

CONTRAST MEDIUM; MION 46L; MONOCRYSTALLINE IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; DEMYELINATION; FEMALE; HISTOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; COLORING AGENTS; CONTRAST MEDIA; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FERROCYANIDES; FERROSOFERRIC OXIDE; IRON; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED STRAINS; OXIDES; RECURRENCE; SENSITIVITY AND SPECIFICITY;

EID: 0032100613     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980601)52:5<549::AID-JNR7>3.0.CO;2-C     Document Type: Article

References (27)

1. Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV, Matthieu JM, Baker D (1994): Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 153:4349-4356.
2. Brocke S, Quigley L, McFarland HF, Steinman L (1996): Isolation and characterization of autoreactive T cells in experimental autoimmune encephalomyelitis of the mouse. Methods Enzymol 9:458-462.
3. Bulte JWM. de Jonge MWA, de Leij L. The TH, Kamman RL, Blaauw B. Zuiderveen F, Go KG (1990): Passage of DMP across a disrupted BBB in the context of antibody-mediated MRI of brain metastases. Acta Neurochir S51:43-45.
4. Bulte JWM, de Jonge MWA, Kamman RL, Go KG, Zuiderveen F, Blaauw B, Oosterbaan JA, The TH, de Leij L (1992): Dextranmagnetite particles: contrast-enhanced MRI of blood-brain barrier disruption in a rat model. Magn Reson Med 23:215-223.
5. 1 NMRD profiles of solutions of monocrystalline iron oxide nanoparticles: theory and experiment. Proceedings of the International Society for Magnetic Resonance in Medicine, Fourth Annual Meeting, New York, 1707.
6. Bulte JWM, Brooks RA, Vymazal J, Frank JA (1996b): 1/T2 NMRD profiles of solutions of monocrystalline iron oxide nanoparticles: theory and experiment. Proceedings of the International Society for Magnetic Resonance in Medicine, Fourth Annual Meeting, New York, 1708.
7. Duckers HJ, Muller HJ, Verhaagen J, Nieolay K, Gispen WH (1997): Longitudinal in vivo magnetic resonance imaging studies in experimental allergic encephalomyelitis: effect of a neurotrophic treatment on cortical lesion development. Neuroscience 77:1163-1173.
8. -. Inorg Chem 29:5109-5113.
9. Karlik SJ, Grant EA, Lee D, Noseworthy JH (1993): Gadolinium enhancement in acute and chronic-progressive experimental allergic encephalomyelitis in the guinea pig. Magn Reson Med 30:326-331.
10. Lublin FD (1996): Experimental models of autoimmune demyelination. In Cook SD (ed): "Handbook of Multiple Sclerosis," 2nd ed. New York: Marcel Dekker, pp 119-143.
11. Martin R, McFarland HF (1995): Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 32:121-182.
12. McFarland HF, Frank JA, Albert PA, Smith ME, Martin R, Harris JO, Patronas N, Maloni H, McFarlin DE (1992): Using gadolinium enhanced MRI to monitor disease activity in multiple sclerosis. Ann Neurol 32:758-766.
13. Miller DH, Albert PS, Barkhof F, Francis G, Frank JA, Hodgkinson S, Lublin FD, Paty DW, Reingold SC. Simon J (1996): Guildelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 39:6-16.
14. Morrissey SP, Stodal H, Zettl U, Simonis C, Jung S, Kiefer R, Lassmann H, Hartung HP, Haase A, Toyka KV (1996): In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic enccphalomyelitis. Brain 119:239-248.
15. Namer IJ. Steibel J. Poulet P, Armspach JP, Mauss Y, Chambron J (1991): In vivo dynamic MRI of MBP-induced acute experimental allergic encephalomyelitis in Lewis rat. Magn Reson Med 24:325-334.
16. Namer IJ, Steibel J, Poulet P, Armspach JP, Mohr M, Mauss Y, Chambron J (1993): Blood-brain barrier breakdown in MBP-specific T cell induced experimental allergic encephalomyelitis. Brain 116:147-159.
17. Neuwelt EA, Weissleder R, Nilaver G, Robert AK, Roman-Goldstein S, Szumowski J. Pagel MA, Jones RS, Remsen LG. McCormick CI, Shannon EM, Muldoon LL (1994): Delivery of virus-sized iron oxide particles to rodent CNS neurons. Neurosurgery 34:777-784.
18. Ostuni JL, Levin RL. Frank JA, DeCarli C (1997): Correspondence of closest edge voxel: a robust registration algorithm. J Magn Reson Imaging 7:410-415.
19. Seeldrayers PA, Syha J, Morrissey SP, Stodal H, Vass K, Jung S, Gneiting T, Lassmann H, Haase A, Hartung HP, Toyka KV (1993): Magnetic resonance imaging investigation of blood-brain barrier damage in adoptive transfer experimental autoimmune encephalomyelitis. J Neuroimmunol 46:199-206.
20. Shen T, Weissleder R, Papisov RM, Bogdanov AAJr, Brady TJ (1993): Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn Reson Med 29:599-604.
21. Stone LA, McFarland H, Frank JA (1996): Neuroimaging in multiple sclerosis. In Stuart C (eds): "Handbook of Multiple Sclerosis," 2nd ed. New York: Marcel Dekker, pp 347-376.
22. Tofts PS (1996): Optimal detection of blood brain barrier defects with GdDTPA MRI-the influences of delayed imaging and optimised repetition time. J Magn Reson Imaging 14:373-380.
23. Weinmann H-J, Brasch RC, Press W-R, Wesbey GE (1984): Characteristics of Gadolinium-DTPA Complex: a potential NMR contrast agent. AJR 142:619-624.
24. Weissleder R (1996): Monocrystalline iron oxide particles for studying biological tissues. U.S. Patent 5,492,814.
25. Weissleder R, Bogdanov A, Neuwelt EA, Papisov M (1996): Longcirculating iron oxides for MRI. Adv Drug Deliv Rev 16:321-334.
26. Xu S, Jordan EK, Li W, Yang Y, Chesnick SA, Webster HD, Brocke S, Quigley L, McFarland HF, Frank JA (1998): In vivo 3D MRI of mice with chronic relapsing experimental autoimmune encephalomyelitis after treatment with insulin-like growth factor I. AJNR (in press).
27. Zimmer C, Weissleder R, O'Connor D, LaPointe L, Brady TJ, Enochs WS (1995): Cerebral iron oxide distribution: in vivo mapping with MRI. Radiology 196:521-527.